Cyclo Therapeutics Overview

Cyclo Therapeutics Operating Income

Operating Income for CYTH.

Quarterly Operating Income

$-8289443.00

↑ 73.88% YoY

As of Sep 30, 2024

Annual Operating Income (TTM)

$-24676903.00

↑ 27.33% YoY

Trailing 12 months ending Sep 30, 2024

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin